TASC Pharma to Merge With Glenmark Laboratories

TASC Pharmaceuticals Ltd., a leading manufacturer of active pharmaceutical ingredients (API) and R&D service provider, said that it will merge with Glenmark Laboratories Ltd., a niche formulations and biopharmaceuticals player, in a deal valued at Rs12bn. The combined entity will be an integrated player both in pharmaceuticals (based on chemical substances) and biopharmaceuticals (based on biologics) with presence over the entire value chain.

Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=64b6291a398b9bb3&cat=6dcd932030878143)